Screening and personality-aspects in post-traumatic stress disorder (PTSD) - substance use disorder patients

ISRCTN ISRCTN42030125
DOI https://doi.org/10.1186/ISRCTN42030125
Secondary identifying numbers NL24822.044.08
Submission date
01/12/2008
Registration date
27/02/2009
Last edited
27/02/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Mr Hein de Haan
Scientific

Keulenstraat 3
Deventer
7418 ET
Netherlands

Study information

Study designObservational cross-sectional study
Primary study designObservational
Secondary study designCross-section survey
Study setting(s)Not specified
Study typeScreening
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleA study on the psychometric qualities of post-traumatic stress disorder (PTSD) screeners and the role of personality (measured by the NEO Five-Factor Inventory [NEO-FFI]) in patients with the comorbid diagnosis of PTSD and substance use disorder (SUD)
Study objectives1. What are the sensitivity and specificity of the Self Inventory List (Zelf inventarisatie lijst [ZIL]) and the post-traumatic stress disorder (PTSD) section of the Mini-International Neuropsychiatric Interview Plus (MINI-PLUS) as a screening instrument for PTSD in substance use disorder (SUD) patients?
2. What are the personality profiles for patients with the comorbid diagnosis of PTSD-SUD?
Ethics approval(s)Medical Ethical Testing Committee (METC) of Medisch Spectrum Twente, approved in November 2008 (ref: NL 24822.044.08).
Health condition(s) or problem(s) studiedPost-traumatic stress disorder, substance use disorder
InterventionThis observational cross-sectional study examines whether patients in four addiction centres meet criteria for PTSD as well as criteria for SUD. Participants will be asked to complete the following assessments in two days:

Day 1:
1. Clinical Interview for PTSD (Klinische Interview voor PTSS [KIP])
2. ZIL
3. M.I.N.I. Plus (PTSD section)

Day 2:
4. Depression Anxiety Stress Scales (DASS)
5. Composite International Diagnostic Interview (CIDI) - Substance Abuse Module (CIDI-SAM)
6. Traumatic Experiences Questionnaire (Vragenlijst Belastende Ervaringen [VBE])
7. European Addiction Severity Index (EuropASI)
8. NEO Five-Factor Inventory (NEO-FFI)
9. Twenty-Item Toronto Alexithymia Scale (TAS-20)
10. Bermont-Vorst Alexithymia Questionnaire (BVAQ)
11. Pictorial Representation of Illness Measure (PRISM)
Intervention typeOther
Primary outcome measure1. Sensitivity and specificity of ZIL and MINI plus (PTSD section), with KIP as gold standard
2. Difference between the NEO FFI profiles of the group PTSD-SUD and the group SUD-PTSD
Secondary outcome measures1. History of several kinds of trauma, severity and time-course are carefully traced by VBE. Comparison will be made between groups that differ in the order of onset of the comorbid disorders, with regard to various outcomes of VBE (nature of trauma, duration, severity, age at onset).
2. Psychometric qualities of DASS in detecting PTSD in relation to other instruments (KIP, ZIL, M.I.N.I.-plus)
3. Alexithymia, assessed by TAS-20 and BVAQ
Overall study start date15/11/2008
Completion date15/06/2009

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants200
Key inclusion criteria1. Patients who are at least 18 years old, both males and females
2. Patients of addiction treatment centres who are inpatient for at least 4 weeks
3. Patients who meet the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (with text revision) (DSM-IV-TR) criteria for Substance Use Disorder
Key exclusion criteria1. Inadequate level of the Dutch language
2. Severe cognitive impairment or damage
3. Severe (self) destructive behaviour

If a practitioner declares the patient is incapable of participation, the patient will be excluded.
Date of first enrolment15/11/2008
Date of final enrolment15/06/2009

Locations

Countries of recruitment

  • Netherlands

Study participating centre

Keulenstraat 3
Deventer
7418 ET
Netherlands

Sponsor information

Tactus Addiction Care Centre (Tactus Verslavingszorg) (Netherlands)
Hospital/treatment centre

Keulenstraat 3
Deventer
7418 ET
Netherlands

Website http://tactus.nl
ROR logo "ROR" https://ror.org/00v0vvh64

Funders

Funder type

Hospital/treatment centre

This study is funded by the following four addiction centres:

No information available

Tactus Addiction Care Centre (Tactus Verslavingszorg) (Netherlands)

No information available

IrisZorg (Netherlands)

No information available

GGZ Noord en Midden Limburg (Netherlands)

No information available

Novadic Kentron (Netherlands)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan